21 studies found for:    "Pneumonia, Pneumococcal"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Terminated Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia
Condition: Pneumonia, Pneumococcal
Interventions: Drug: levofloxacin;   Drug: ceftriaxone
2 Completed New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)
Conditions: Pneumonia, Pneumococcal;   Community Acquired Infections;   Gram-positive Bacterial Infections
Intervention: Drug: Antibiotic
3 Completed Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia
Conditions: Pneumonia, Pneumococcal;   Vaccines, Pneumococcal
Intervention: Procedure: Urine sample collection
4 Active, not recruiting Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae
Conditions: Pneumococcal Infections;   Pneumonia, Pneumococcal
Interventions: Biological: GEN-004 with Aluminum Hydroxide Adjuvant;   Biological: Placebo
5 Active, not recruiting Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers
Condition: Pneumonia, Pneumococcal
Interventions: Biological: PATH-wSP;   Biological: pneumococcal polysaccharide conjugate vaccine (adsorbed);   Biological: Diptheria Pertussis Tetanus Hep B Haemophilus b Conjugate;   Other: Saline
6 Completed
Has Results
Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults
Conditions: Pneumonia, Pneumococcal;   Pneumococcal Infections;   13-valent Pneumococcal Vaccine
Interventions: Biological: VACCINE: placebo;   Biological: VACCINE: 13-valent pneumococcal conjugate vaccine
7 Completed Targeting of Immune Response After Pneumococcal Vaccination
Condition: Pneumococcal Pneumonia
Interventions: Biological: Pneumococcal polysaccharide vaccine;   Biological: pneumococcal conjugate vaccine
8 Unknown  PCV10 Reactogenicity and Immunogenicity Study - Malindi
Condition: Pneumococcal Pneumonia
Interventions: Biological: PCV10 and DTaP;   Biological: hepatitis A vaccine, DTaP, PCV10
9 Completed Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults
Conditions: Pneumococcal Infections;   Streptococcus Pneumoniae Infections;   Pneumococcal Pneumonia
Interventions: Biological: Pneumococcal vaccine Formulation 1;   Biological: Pneumococcal vaccine Formulation 2;   Biological: Pneumococcal vaccine Formulation 3;   Biological: Placebo
10 Completed Study of Two Investigational Pneumococcal Vaccines in Healthy Adults
Conditions: Pneumococcal Infections;   Streptococcus Pneumoniae Infections;   Pneumococcal Pneumonia
Interventions: Biological: Pneumococcal Vaccine Formulation 1;   Biological: Pneumococcal Vaccine Formulation 2;   Biological: Pneumococcal Vaccine Formulation 3;   Biological: Pneumococcal Vaccine Formulation 4;   Biological: Pneumococcal Vaccine Formulation 5;   Biological: Placebo
11 Completed Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers
Conditions: Pneumococcal Infections;   Pneumococcal Pneumonia
Intervention: Biological: Pneumococcal Vaccine
12 Recruiting The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses
Conditions: Rotavirus Infections;   Intestinal Bacteria Flora Disturbance;   Reaction - Vaccine Nos;   Tetanus;   Streptococcal Pneumonia
Intervention: Biological: Rotavirus vaccine, Tetanus vaccine and Pneumococcal vaccine
13 Completed PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae
Conditions: Streptococcal Pneumonia;   Nasopharyngeal Diseases;   Vaccination Adverse Event
Interventions: Biological: PCV7 (Pneumococcal 7-Valent Conjugate Vaccine);   Biological: Hib Vaccine
14 Completed Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.
Condition: Community-acquired Pneumonia
Intervention: Procedure: Observation
15 Withdrawn Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals
Condition: HIV Infections
Interventions: Biological: Influenza Virus Vaccine;   Biological: Pneumococcal Vaccine, Polyvalent (23-valent);   Drug: Lamivudine
16 Completed Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.
Condition: Infections, Streptococcal
Intervention: Biological: 10 valent pneumococcal conjugate (vaccine)
17 Completed Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine
Condition: Pneumococcal Disease
Intervention: Biological: 10 valent pneumococcal conjugate (vaccine)
18 Completed
Has Results
Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients
Condition: Leukemia
Interventions: Drug: Sargramostim (GM-CSF);   Biological: Pneumococcal Vaccine
19 Completed Humoral Determinants of Immunity to Pneumococcal Infection
Conditions: Pneumonia;   Pneumococcal Infections;   Infections, Streptococcus Pneumoniae
Interventions: Biological: Prevnar;   Biological: Pneumovax
20 Completed Invasive Infections in Children With Hemoglobinopathies
Conditions: Thalassemia;   Sickle Cell Anemia
Intervention: Procedure: Historical records

   Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results    Last Page
Indicates status has not been verified in more than two years